Michael Byrnes

Form D signer

Michael Byrnes

Chief Financial Officer at Fore Biotherapeutics

Form D signer

Capital raised by Fore Biotherapeutics

$70.4M+$70.4M latest round

1 Form D filing · first filed Apr 2025 · Philadelphia, PA

CURRENT ROLE: Chief Financial Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2022
30D INTEREST: —

Career

1 company on file · founded 2022

Fore BiotherapeuticsBiotech · Philadelphia, PAsince 2022

Chief Financial Officer

Signatory on Fore Biotherapeutics's Form D filings · $70.4M raised across 1

Company filings

via EDGAR · Form D for Fore Biotherapeutics1

DateCompanyFormAmountRole on filing

Apr 30, 2025Fore BiotherapeuticsForm D/A+$70.4MChief Financial Officer

Form D/AApr 30, 2025 · Fore Biotherapeutics+$70.4Mas Chief Financial Officer

Overview

Last filing Apr 30, 2025

Michael Byrnes is on file as Chief Financial Officer at Fore Biotherapeutics in Philadelphia, PA. Fore Biotherapeutics has 1 Form D filing on record, $70.4M raised in total. Michael Byrnes appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Fore Biotherapeutics · 1

Kim BlackwellDirector

Products

Fore Biotherapeutics · 1

PlixorafenibOncology drug candidate

An investigational, next-generation small-molecule BRAF inhibitor targeting a broad range of BRAF gene alterations in solid and CNS tumors, in registration-intended Phase 2 development.